NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE274660 Query DataSets for GSE274660
Status Public on Aug 13, 2024
Title Epigenetic insights into GABAergic development in Dravet Syndrome iPSC and therapeutic implications
Organism Homo sapiens
Experiment type Genome binding/occupancy profiling by high throughput sequencing
Summary Dravet syndrome (DS) is a devastating early onset refractory epilepsy syndrome caused by variants in the SCN1A gene. A disturbed GABAergic interneuron function is implicated in the progression to DS but the underlying developmental and pathophysiological mechanisms remain elusive, in particularly at the chromatin level. In this study, we utilized induced pluripotent stem cells (iPSCs) derived from DS cases and healthy donors to model disease-associated epigenetic abnormalities of GABAergic development. Employing the ATAC-Seq technique, we assessed chromatin accessibility at multiple time points (Day 0, Day 19, Day 35, and Day 65) of GABAergic differentiation. Additionally, we elucidated the effects of the commonly used anti-seizure drug valproic acid (VPA) on chromatin accessibility in GABAergic cells. The distinct dynamics in chromatin profile of DS iPSC predicted accelerated early GABAergic development, evident at D19, and diverged further from the pattern in control iPSC with continued differentiation, indicating a disrupted GABAergic maturation. Exposure to VPA at D65 reshaped the chromatin landscape at a variable extent in different iPSC-lines and rescued the observed dysfunctional development in some DS iPSC-GABA. This study provides the first comprehensive investigation on the chromatin landscape of GABAergic differentiation in DS-patient iPSC, offering valuable insights into the epigenetic dysregulations associated with interneuronal dysfunction in DS. Moreover, our detailed analysis of the chromatin changes induced by VPA in iPSC-GABA holds the potential to improve development of personalized and targeted anti-epileptic therapies.
 
Overall design Dynamic change of chromatin accessbility in GABAergic development from Dravet Syndrome iPSC
 
Contributor(s) xingqi c, xingqi c
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Aug 13, 2024
Last update date Aug 14, 2024
Contact name Xingqi Chen
E-mail(s) xingqi.chen@igp.uu.se
Organization name uppsala university
Department Immunology, Genetics and Pathology
Lab Molecular tools
Street address Husargata
City Uppsala
ZIP/Postal code 752 37
Country Sweden
 
Platforms (1)
GPL24676 Illumina NovaSeq 6000 (Homo sapiens)
Samples (56)
GSM8454254 Ctl1B_Day0_repl1
GSM8454255 Ctl1B_Day0_repl2
GSM8454256 Ctl1B_Day19_repl1
Relations
BioProject PRJNA1147601

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE274660_RAW.tar 16.1 Gb (http)(custom) TAR (of BW)
SRA Run SelectorHelp
Raw data are available in SRA

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap